| scholarly article | Q13442814 |
| P50 | author | Robert Heyderman | Q60016666 |
| P2093 | author name string | Heyderman RS | |
| P2860 | cites work | Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates | Q28307132 |
| Intravascular coagulation in fulminant meningococcemia | Q33467857 | ||
| Changes in the blood coagulation system associated with septicemia | Q33472504 | ||
| Sepsis and septic shock: a review for clinicians | Q35536770 | ||
| Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation | Q35587275 | ||
| Fulminating meningococcic infections and the so-called Waterhouse-Friderichsen syndrome | Q35930937 | ||
| Modulators of coagulation. A critical appraisal of their role in sepsis | Q36306304 | ||
| Activated leukocytes and the hemostatic system. | Q39681909 | ||
| Disseminated intravascular coagulation (DIC): An approach | Q39915056 | ||
| Severity of meningococcal disease: assessment by factors and scores and implications for patient management | Q40756780 | ||
| Deficiency of prostacyclin production in meningococcal shock | Q41809025 | ||
| Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody | Q43590664 | ||
| Meningococcal purpura: report of 19 patients treated with heparin | Q43730522 | ||
| Purified fibronectin administration to patients with severe abdominal infections. A controlled clinical trial | Q45213289 | ||
| Beneficial effects of prostacyclin in a rabbit endotoxin shock model | Q45388758 | ||
| Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? | Q54282836 | ||
| Reduction of the anticoagulant activity of glycosaminoglycans on the surface of the vascular endothelium by endotoxin and neutrophils: evaluation by an amidolytic assay | Q54672978 | ||
| Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils | Q54675259 | ||
| Unorthodox use of aprotinin to control life-threatening bleeding after cardiopulmonary bypass | Q67656097 | ||
| Combined activation of platelets by cathepsin G and platelet activating factor, two neutrophil-derived agonists | Q68077850 | ||
| Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease | Q68733561 | ||
| Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura | Q70397635 | ||
| An appraisal of fulminant meningococcemia with reference to the Shartzman phenomenon | Q78459051 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sepsis | Q183134 |
| thrombosis | Q261327 | ||
| P304 | page(s) | 621-623 | |
| P577 | publication date | 1993-05-01 | |
| P1433 | published in | Archives of Disease in Childhood | Q4787296 |
| P1476 | title | Sepsis and intravascular thrombosis | |
| P478 | volume | 68 |
| Q73089506 | Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease |
| Q37603334 | Identification of differentially expressed serum proteins in infectious purpura fulminans. |
| Q70907143 | Modulation of the endothelial procoagulant response to lipopolysaccharide and tumour necrosis factor-alpha in-vitro: the effects of dexamethasone, pentoxifylline, iloprost and a polyclonal anti-human IL-1 alpha antibody |
| Q33498929 | Prediction of neonatal sepsis by thromboelastography |
| Q33997749 | Recognition, treatment and complications of meningococcal disease |
| Q56172334 | Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans |
Search more.